Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 817-822 , August 2000

Competing risk adjustment reduces overestimation of opportunistic infection rates in AIDS

  • Yan Yan

      Affiliations

    • Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA
    • Corresponding Author InformationCorresponding author. Department of Surgery, Washington University Medical School, 4960 Children's Place, St. Louis, MO. 63110, USA. Tel: 314-362-9290; Fax: 314-362-9275. E-mail address:
    • ,
  • Richard D Moore

      Affiliations

    • Department of Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    • ,
  • Donald R Hoover

      Affiliations

    • Department of Statistics and Center for Health Care Policy and Aging Research, Rutgers University, Piscataway, NJ, USA

Received 7 February 1999 ,Accepted 22 December 1999.

References 

  1. Mocroft AJ, Lundgren JD, d'Armino Monforte A, et al.  Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol. 1997;26(2):400–407
  2. Lepri AC, Sabin CA, Pezotti P, England PD, Philips AN, Rezza G. Is there a general tendency for CD4 lymphocyte decline to speed up during human immunodeficiency virus infection? Evidence from the Italian Seroconversion Study. J Infect Dis. 1997;175(4):775–780
  3. Rizzardi GP, Lazzarin A, Musicco M, Frigerio D, Maillard M, Lucchini M, et al. Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinni pneumonia in patients with AIDS. An Italian multicentric randomized controlled trial. The Italian PCP Study Group. J Infect. 1995;31(2):99–105
  4. Derouin F, Leport C, Pueyo S, et al.  Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV-infected patients. AIDS. 1996;10(13):1521–1527
  5. Dore GJ, Li Y, Grulich AE, et al.  Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia (the Australian AIDS cohort). AIDS. 1996;10(12):1401–1406
  6. Conley LJ, Bush TJ, Buchbinder SP, Penley KA, Judson FN, Holmberg SD. The association between cigarette smoking and selected HIV-related medical conditions. AIDS. 1996;10(10):1121–1126
  7. Ridolfo AL, Santambrogio S, Mainini F, et al.  High frequency of non-Hodgkin's lymphoma in patients with HIV-associated Kaposi's sarcoma. AIDS. 1996;10(2):181–185
  8. Carre N, Meyer L, Boufassa F, et al.  High risk of HIV disease progression after infection through a sexual partner with AIDS. AIDS. 1996;10(1):77–80
  9. Hermans P, Lundgren J, Sommereijns B, et al.  Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study Group. AIDS. 1997;11(4):525–531
  10. Stroud S, Salvato P, Thompson C, Knight B, Carroll E. Active cytomegalovirus infection and disease progression in patients with HIV disease. Int Conf AIDS. 1992;8(2):B146;(abstract no PoB 3354).
  11. Hawley-Foss N, Wells G, Leonard B, Cameron DW. Incidence and course of Cytomegalovirus retinitis in HIV. Int Conf AIDS. 1993;9(1):347;(abstract no PoB 08-1270).
  12. Wang F, So Y, Vittinghoff E, et al.  Incidence proportion of and risk factor for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis and cryptococal meningitis. J Acquir Immune Defic Syndr. 1995;8(1):75–82
  13. Colford JM, Ngo L, Tager I. Factors associated with survival in human immunodeficiency virus-infected patients with very low CD4 counts. Am J Epidemiol. 1994;139:206–218
  14. Graham NM, Hoover DR, Park LP, et al.  Survival in HIV-infected patients who have received Zidovudine (comparison of combination therapy with sequential monotherapy and continued Zidovudine monotherapy). Ann Intern Med. 1996;124:1031–1038
  15. Stein DS, Graham NM, Park LP, et al.  The effect of the interaction of Acyclovior wit Zidovudine on progression to AIDS and survival. Ann Intern Med. 1994;121:100–108
  16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  17. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187–220
  18. Hoover DR, Peng Y, Saah AJ, et al.  Projecting disease when death is likely. Am J Epidemiol. 1996;143(9):943–952
  19. Anderson PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. New York, NY: Springer-Verlag; 1993;
  20. SAS Institute . SAS software, version 6.12. Cary, NC: SAS Institute; 1996;
  21. Hoover DR, Peng Y, Saah AJ, et al.  Using multiple decrement models to estimate risk and morbidity from specific AIDS illnesses. Stat Med. 1996;15:2307–2321
  22. Hoover DR, Peng Y. User's Manual of MULTDEC (Multiple Decrement Model Transition Program). Baltimore, MD: Johns Hopkins University; 1995;
  23. Gallant JE, Moore RD, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with Zidovudine. J Infect Dis. 1992;166:1223–1227
  24. Yan Y. Two Sandwiching Multiple Decrement Covariate Model and Its Applications in AIDS Epidemiology (Ph.D dissertation). Baltimore, MD: Johns Hopkins University; 1998;
  25. Palella FJ, Delaney KM, Moorman AC, et al.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–860

PII: S0895-4356(99)00235-8

Journal of Clinical Epidemiology
Volume 53, Issue 8 , Pages 817-822 , August 2000

Article Tools